Measurement of Resistance During UAS Insertion Procedure in RIRS
Measurement of Resistance During UAS Insertion Procedure in RIRS: the Effects of Bladder Filling Degree and the Assessment of Ureter Injury.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Guohua Zeng, Ph.D and M.D
- Phone Number: +8613802916676
- Email: gzgyzgh@vip.tom.com
Study Contact Backup
- Name: Wen Zhong, Ph.D and M.D
- Phone Number: +8613631320020
- Email: gzgyzhongwen@163.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510230
- Recruiting
- Department of Urology, Minimally invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
-
Contact:
- Zhong Wen, Ph.D & MD.
- Phone Number: +8613631320020
- Email: gzgyzhongwen@163.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients must be a suitable operative candidate for RIRS
- Age 18 to 70 years
- Normal renal function 4 .ASA score Ⅰ and Ⅱ
5. Single renal or ureteral stone ≤20mm or multiple stones the conglomerate diameter (additive maximal diameter of all stones on axial imaging of computed tomography) up to 20 mm
Exclusion Criteria:
- Uncorrected coagulopathy and active urinary tract infection (UTI)
- Severe cardiopulmonary dysfunction, can not tolerate sugery
- Patients who underwent transplant or urinary diversion
- Definite diagnosis of ureteral stricture or a history of stricture
- The bladder volume is less than 100ml
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group 1: empty bladder
In group 1, investigator empty the bladder of urine with a catheter before inserting UAS.
|
In group 1, investigator empty the bladder of urine with a catheter before inserting UAS, so that we can see if the empty bladder is easier for inserting UAS.
|
|
Active Comparator: Group 2: natural state of bladder
In group 2, investigator does not interfere with the filling degree of bladder before inserting UAS.
|
In group 2, investigator does not interfere with the filling degree of bladder before inserting UAS, so that we can see if the filling degree of bladder has impact on the insertion of UAS.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
UAS insertion success rate
Time Frame: intraoperatively
|
Primary insertion of a UAS is not always successful.
The ideal position of the UAS is with its distal extremity just below the ureteric-pelvic junction (UPJ).
Insertion failure is defined as UAS cross the upj or do not reach the proximal ureter or the surgeon's decision to resign UAS insertion due to high resistance to the retrograde progression of the UAS along the urinary tract.
|
intraoperatively
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ureteral lesion grade
Time Frame: intraoperatively
|
Base on post-ureteroscopic lesion scale (PULS), reported by Traxer O and Thomas A in 2013.
UAS related ureteral injuries were divided into 5 grades according to ureteral wall anatomy.
Grade 0 means no lesion found or only mucosal petechiae.
Grade 1 means ureteral mucosal erosion without smooth muscle injury.
Both Grade 0 and Grade 1 are considered as low-level injuries.
Grade 2 means ureteral wall injury, including mucosa and smooth muscle, with adventitial preservation (periureteral fat not seen).
Grade 3 means ureteral injury indicated ureteral perforation involving the full thickness of the ureteral wall, including the adventitia.
Grade 4 means injury corresponded to total ureteral avulsion with complete rupture of ureteral continuity.
Grade 2, 3 and 4 are high-level injuries.
|
intraoperatively
|
|
resistance of UAS insertion
Time Frame: intraoperatively
|
The dynamometer was used to measure the resistance of UAS insertion procedure in both two groups, so as to analysis the relationship between bladder filling degree and inserting resistance.
|
intraoperatively
|
|
Complication rate
Time Frame: 1 month after removing the pigtail stent
|
Complication is defined as any adverse event occurred intraoperatively or ≤1 month postoperatively, including intraoperative bleeding, postoperative pain and so on.The investigator will invaluate perioperative complications by modified Clavien system
|
1 month after removing the pigtail stent
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MRER(78)2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.